APA

Dillingham B. C., Knoblach S. M., Many G. M., Harmon B. T., Mullen A. M., Heier C. R., Bello L., McCall J. M., Hoffman E. P., Connor E. M., Nagaraju K., Reeves E. K. M. & Damsker J. M. (20160104). VBP15, a novel anti-inflammatory, is effective at reducing the severity of murine experimental autoimmune encephalomyelitis. : Cellular and molecular neurobiology.

Chicago

Dillingham Blythe C, Knoblach Susan M, Many Gina M, Harmon Brennan T, Mullen Amanda M, Heier Christopher R, Bello Luca, McCall John M, Hoffman Eric P, Connor Edward M, Nagaraju Kanneboyina, Reeves Erica K M and Damsker Jesse M. 20160104. VBP15, a novel anti-inflammatory, is effective at reducing the severity of murine experimental autoimmune encephalomyelitis. : Cellular and molecular neurobiology.

Harvard

Dillingham B. C., Knoblach S. M., Many G. M., Harmon B. T., Mullen A. M., Heier C. R., Bello L., McCall J. M., Hoffman E. P., Connor E. M., Nagaraju K., Reeves E. K. M. and Damsker J. M. (20160104). VBP15, a novel anti-inflammatory, is effective at reducing the severity of murine experimental autoimmune encephalomyelitis. : Cellular and molecular neurobiology.

MLA

Dillingham Blythe C, Knoblach Susan M, Many Gina M, Harmon Brennan T, Mullen Amanda M, Heier Christopher R, Bello Luca, McCall John M, Hoffman Eric P, Connor Edward M, Nagaraju Kanneboyina, Reeves Erica K M and Damsker Jesse M. VBP15, a novel anti-inflammatory, is effective at reducing the severity of murine experimental autoimmune encephalomyelitis. : Cellular and molecular neurobiology. 20160104.